ReviewFrontiers in public health2026
Durability of COVID-19 vaccine-induced immunity in Saudi Arabia: evidence, gaps, and implications for Hajj and mass-gathering preparedness.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The policy question for COVID-19 vaccination has shifted from whether vaccines induce protection to how long clinically meaningful protection persists and how immune information should guide preparedness. This question is especially relevant to Saudi Arabia, where Hajj and Umrah create predictable periods of dense population mixing among pilgrims with diverse vaccination histories, prior infection exposures, ages, and comorbidity profiles. This structured narrative review synthesizes evidence on durability of COVID-19 vaccine-induced immunity, Saudi epidemiological and serological data, heterologous booster strategies, hybrid immunity, and operational implications for mass-gathering preparedness. A structured search of biomedical databases and public-health sources was undertaken for evidence published from January 2020 to May 2026. The review highlights those circulating antibodies and neutralizing activity decline after vaccination, particularly against antigenically divergent variants, whereas memory B-cell responses and CD4+ and CD8+ T-cell immunity generally provide more durable protection against severe disease. Saudi evidence remains limited but informative: national seroprevalence studies, vaccine-rollout data, clinical-effectiveness analyses, and recent serological work indicate substantial prior exposure, strong post-vaccination antibody responses, and meaningful protection against hospitalization and intensive-care admission, particularly after booster dosing. Heterologous schedules and hybrid immunity appear to broaden immune protection, but their policy relevance lies in flexible risk-based planning rather than in promoting infection as a strategy. For Hajj and Umrah, the main implication is a shift from simple dose counting toward immune durability, risk stratification, booster timing, vaccination documentation, genomic surveillance, and integrated respiratory-virus monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.